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Abstract 
Growing increasingly in South America, Africa and Asia, breast cancer is known as the dominant 
type of cancer in women. Different treatments are available for breast cancer, among which 
surgery is the most widely used, but researchers are trying to develop new strategies. One of the 
most prominent surgical methods is referred to as oncoplastic surgery, that helps to remove 
segments of malignant breast tissue. This type of surgery aims to obtain vast surgical margins, 
while the remaining tissue is rearranged so that the better cosmetic outcome is obtained. This 
review will investigate the breast cancer and then discuss partial breast reconstruction. Before 
outlining the procedures, the different types of partial breast reconstruction will be discussed. 
Finally, advantages and disadvantages will be outlined. MEDLINE database was used to conduct 
the search. The main terms used were ‘Conservation Breast Surgery Reconstruction’ AND 
‘Oncoplastic Surgery’, ‘Partial Mastectomy Reconstruction’ AND ‘Conservative Breast Surgery 
Reconstruction’, ‘oncoplastic’ [All Fields], ‘breast’ AND ‘surgery’ OR ‘surgery’ operative’, 
‘oncoplastic’ (‘breast’)’. The bibliographies of relevant papers were manually searched up to 
October 2018, but more recent voices are also included. 
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 Breast cancer is known as the dominant type of cancer 
in women, about 232,000 cases are reported annually in 
the United States.1,2 Breast cancer constitutes 22.9% of 
all invasive cancers in women. Invasive breast cancer 
refers to a cancer which affects ducts, glands and other 
parts of the breast.3  
Prevalence and Risk Factors  
The incidence of breast cancers grows with increasing 
age. The Centers for Disease Control and Prevention 
reported that the age group 70-74 years is most 
vulnerable. According to the UK Cancer Research, 
approximately 54,900 cases of breast cancer are reported 
annually in the UK. Furthermore, it is the most common 
type of cancer in the UK, accounting for 15% of all new 
cases.4 Breast cancer is the most common invasive cancer 
in women worldwide, affecting 12% of women.  
Several risk factors for breast cancer are presented in 
Table 1.5 
Benign breast disease 
Non-invasive non-melanoma breast skin tumor is the 
most common begnin diesease, that it is easy to treat. 
Indeed it accounts to few deaths. Genetics, higher levels 
of hormones, obesity, dietary patterns and lack of 
breastfeeding are some of the main risk factors. Exposure 
to light pollution can increase the likelihood of breast 
cancer. Changes in hormone balances during normal, 
monthly menstrual cycles can lead to symptomatic breast 
changes for some women. Cysts are defined as tiny, 
benign, fluid-filled sacs that are problematic for women. 
Lump size may intensify the week before the menstrual 
period and lessen a week after. Some benign breast 
conditions include gynaecomastia, benign phyllodes 
tumor, breast pain, breast cysts, breast calcifications, 
Lobular neoplasia, sclerosing lesions of the breast, 
Mondor’s disease, duct ectasia, intraductal papilloma, 
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breast), periductal mastitis, fat necrosis and atypical 
hyperplasia.6 
Clinical Presentation of Breast Cancer 
Some of the main symptoms include pain in breast or 
pain in the nipple area, new lump in the breast, thickening 
or swelling of part of the breast, nipple discharge other 
than breast milk, new lump in the breast or underarm, 
redness or flaky skin in the nipple, dimpling of breast skin 
and change in the size or the shape of the breast.7, 8 
Types of Breast Cancer 
Breast cancer may develop in the lobules, the milk ducts 
or the tissue in between.9 Different types of breast cancer 
are presented in Table 2. 
Diagnosis 
Several types of breast cancer can be diagnosed with 
biopsy of the affected area in the breast. However, some 
types of breast cancer need specialized laboratory 
examinations. Mammography and physical examination 
of the breasts can determine whether a lump is a cancer. 
These two methods may also be used to detect some other 
lesions. Some of the most common methods of diagnosis 
include Axillary lymph node dissection, Lymph node 
biopsy, including Sentinel lymph node biopsy, Health 
history and physical exam, Fine needle aspiration, 
Diagnostic mammography, human epidermal growth 
factor receptor 2 status testing, Hormone receptor status 
testing (such as estrogen receptors, Scintimammography 
and progesterone receptors.10,11 
Treatment of Breast Cancer 
Breast cancer can be treated with several methods. 
Surgery is the most widely used method that removes 
physically the tumor.12,13 Some types of treatments for 
breast cancer are outlined as follows. 
Therapies with drugs 
In this type of therapy, chemical drugs are used to kill the 
cancer cells. Some of the systemic therapies used in this 
area include hormonal therapy, chemotherapy and 
targeted therapy.14-17 The most commonly used drugs for 
chemotherapy are summarized in Table 3. 
Radiation Therapy 
Radiotherapy can be used to kill tumor cells. It may 
positively affect the tumor microenvironment. 
Brachytherapy (internal radiotherapy) and external beam 
Table 1. Risk factors of brest cancer 
 
Risk factor Explanation 
Age Older women are more likely to develop breast cancer. 
Family History Women with a history of breast cancer are more likely to develop breast cancer. 
Genetics Approximately 5% to 10% of breast cancers are attributed to hereditary factors. 
History of Breast Cancer 
 
Patients with breast cancer are more likely to develop a new cancer in the other breast or a 
different part of the same breast. 
Certain Breast Changes Several types of benign breast conditions may affect breast cancer risk. 




Smoking is reported to increase the risk of developing breast cancer in younger, premenopausal 
women. 
Diet According to the reports, diet accounts for approximately 30% to 40% of all cancers. 
Dense Breasts 
 
According to the reports, dense breasts are 6 times more likely to develop cancer. This can 
complicate the detection of breast cancer. 
 
 
Table 3.  Chemotherapy drugs for breast cancer 
 
 Vinorelbine (Navelbine) 
 Protein-bound paclitaxel (Abraxane) 
 Paclitaxel (Taxol) 
 Methotrexate (Rheumatrex, Trexall) 
 Ixabepilone (Ixempra) 
 Gemcitabine (Gemzar) 
 Fluorouracil (5-FU, Efudex) 
 Doxorubicin 
 Docetaxel (Taxotere) 
 Cyclophosphamide 
 Eribulin (Halaven) 
 Epirubicin (Ellence) 
 Pegylated liposomal doxorubicin (Doxil) 
 Cisplatin 
 Carboplatin 
 Capecitabine (Xeloda) 
 
 
Table 2. Types of brest cancer 
 
• Inflammatory Breast Cancer 
•  Medullary Carcinoma of the Breast 
• Ductal Carcinoma In Situ 
• Lobular Carcinoma In Situ 
• Invasive Ductal Carcinoma 
•  Papillary Carcinoma of the Breast 
•  Mucinous Carcinoma of the Breast 
• Invasive Lobular Carcinoma 
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radiotherapy are two types of radiotherapy. Radiation can 
also be delivered during the operation on the breast 
cancer. The common types of radiation therapy are 
presented in Table 4. 
Surgery 
Some of the treatments include targeted therapy, 
chemotherapy,  radiation therapy, surgery and hormonal 
therapy. Surgeries may range from mastectomy to breast-
conserving surgery. Breast reconstruction can be applied 
during the surgery or later. Cancers with greater risk of 
recurrence may be treated with surgery. Mastectomy is 
used to remove the entire breast, while lumpectomy aims 
to remove the suspicious or cancerous spot. The physical 
removal of the tumor occurs during surgery. It is possible 
to perform biopsy on one or more lymph nodes during 
the surgery.18 Some women prefer to undergo 
contralateral prophylactic mastectomy. Non-surgical 
methods such as radiation therapy are used to target and 
destroy the cancerous cells.19,20). Breast reconstruction 
may be performed during surgery or later. Once cancer 
spreads to other parts of the body, treatments attempt to 
improve the quality of life of the patients. Nipple 
prosthesis can be applied, once the mastectomy is over.21 
There are two main purposes behind breast cancer 
surgery. This type of surgery aims to treat the breast 
cancer successfully and reconstruct the psychosocial 
perspectives, including image and sexual well-being or 
self-perception.22 It is important for women to be able to 
wear a bra and feel physically balanced in breast shape 
and size.23 The two purposes mentioned above should be 
taken into consideration in order to make appropriate 
decisions for breast cancer treatment. Surgeries may 
range from mastectomy to breast-conserving surgery. 
Combined with breast conservation therapy (BCT), 
oncoplastic approach can be used to treat breast cancer. 
Women with breast cancer are reportedly more 
comfortable with this safe method. Using this therapy, 
they can save breast tissue and shape.24 Accordingly, 
BCT, by combining the oncology principles with plastic 
surgery, contributes to the appropriate management of 
cancer. Furthermore, it improves tumor extirpation and 
minimizes the potential for a BCT deformity. Partial 
breast reconstruction was first introduced in the UK in 
1990s. The patients are mostly concerned about the 
choice between breast conservation and mastectomy. For 
this purpose, plastic surgeons and surgical oncologist can 
help patients make the right decision.25,26 
Partial Breast Defects Classification and Oncoplastic 
Techniques for Type of Breast Defects 
Breast deformities can be classified by several methods. 
Some of the most important classifications include breast 
reshaping, primary closure and local and distant flaps 
The oncoplastic techniques which can be used for 
different types of breast defects are presented in Table 5. 
It should be pointed out that some of the classifications 
are associated with delayed reconstruction.27 Considering 
the response to reconstruction, Clough et al. could 
classify the oncoplastic procedures and breast defects. 
Patients who suffer from Type-I breast deformity have 
normally shaped breast, without any other deformities. 
However, patients with Type-II deformity usually suffer 
from deformed breasts. They are typically treated with 
reconstruction or mastectomy.28 Partial mastectomy-
related breast deformity can mostly be reduced. Partial 
breast reconstruction can be used after the partial 
mastectomy. There is no need for reconstruction in small 
Table 4. Radiation therapy for breast cancer 
 
• External-beam radiation therapy: Known as the 
most common type of radiation treatment, external 
beam radiotherapy is delivered outside the body 
using a machine. 
• Brachytherapy: This therapy beams radioactive 
sources into the tumor. 
• Intra-operative radiation therapy: A probe is used 
to perform this type of therapy. 
Table 5. Different types of breast defects and suggested oncoplastic techniques 
 
Type of breast defects Oncoplastic technique required 
Types IA, IIA and IIIA 
 
Breast tissue advancement flaps 
Type IB 
 






Lateral Thoracodorsal Flap or 
Latissimus Dorsi Myocutaneous Flap 
Type IIIB 
 
Bilateral Reduction Mammaplasty 
Type IIIC 
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defects in large breasts. For larger defects, breast 
reshaping and a contralateral breast reduction can be 
taken into consideration. For this purpose, it is necessary 
to choose appropriate techniques or a combination of 
procedures. It should be mentioned that reconstruction 
techniques are often performed with bilateral reduction 
mammaplasty, latissimus dorsi myocutaneous flap, 
breast tissue advancement flaps, abdominal flaps, 
bilateral mastopexy, and lateral thoracodorsal flap. 
Regarding the use of distant flaps in CBS, more 
appropriate techniques have been unanimously chosen.29 
Size and location of tumor in breast are two of the 
influencing factors that should be taken into 
consideration. In some patients, chemotherapy may be 
used to shrink the tumor. Once that process is over, the 
patients may undergo surgery.30,31 Plastic surgeon may 
evaluate the degree of ptosis, any evidence of prior 
radiation, overall skin quality and breast size. The size of 
the breast and affected region should be paid great 
attention (Figure 1). Patient with smaller size of breast 
suffer from low volume of glandular tissue. For this 
purpose, they may be in need of regionally-based flaps. 
It is essential to apply oncoplastic principles to 
reconstruction and mastectomy. It is also important to 
understand different varieties of mastectomy techniques 
in order to obtain the optimal outcomes. Given the tumor 
location, the appropriate reduction technique and the 
design of the nipple/areolar pedicle are selected.32,33 
While maintaining the breast shape and appearance, the 
cancer may be resected with surgical margins. For a 
surgery to be performed successfully, it is necessary to 
use breast imaging because it is capable of predicting the 
orientation of disease and histological extent accurately. 
Mammography detects asymptomatic breast cancers 
Imaging methods can be efficiently used to diagnose the 
tumor mass.34 Volume replacement and volume 
displacement are among the most widely used types of 
reconstruction, each of which have different techniques. 
Some of the techniques specifically attributed to the 
volume replacement are primary closure mirror (such as 
biopsy/excisions; batwing mastopexy), reduction 
mastopexy, breast flap and parenchymal (such as 
remodeling, volume shrinkage).35 While the techniques 
specifically attributed to the volume replacement are 
distant flaps, adjacent or distant tissue transfer, local flaps 
(such as fascio cutaneous, perforator), implant 
augmentation and volume preserving. Depending on the 
size of tumor, location of tumor, breast size and patient’s 
desires, volume displacement may seem much more 
appropriate.36 Oncoplastic surgery is a combination of 
the principles of plastic surgery and oncology. It uses 
breast flap advancement to address tissue defects and 
improve cosmesis. Breast conserving surgery (BCS) 
followed by radiation treatment comprises BCT. Masetti 
et al. developed a four-step design for oncoplastic 
operations which can be applied in several cases.21,37,38 
Fundamentally, oncoplastic procedures attempt to 
minimize cosmetic detriment to the breast. 
Clinical Outcomes of Breast Reconstruction 
Breast cancer reconstruction still remains a challenging 
area for oncologists and plastic surgeons. Before 
performing radiotherapy, an optimal treatment is 
needed.25,39 So far, there is not sufficient evidence for the 
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aesthetic clinical and safety results of the oncoplastic 
techniques. This can be attributed to the small number of 
patients and less experienced surgeons. In the past, 
cancer was described as a systemic illness, Then, several 
sparing procedures were developed. However, it is 
necessary to collect sufficient data on the metastasis and 
overall survival in these procedures.40 Kronowitz et al. 
examined 69 patients and reported recurrent oncoplastic 
reconstructions (P=0.06).25 In addition, Clough et al.28 
investigated the patients who had undergone oncoplastic 
reconstruction and BCS. Local recurrence was reported 
in 11 cases (5-year local recurrence rate was 9.4%). 
Accordingly, 8 patients died and 13 patients developed 
metastases.41 Oncoplastic procedures suffer from limited 
evidence regarding the aesthetic results. There are several 
methods for aesthetic evaluation.42 According to some 
authors, glandular and skin tissue resection can affect the 
aesthetic outcome.43 
Advantages and Disadvantages of Partial Breast 
Reconstruction 
Mastectomy and implant reconstruction offers several 
advantages for good candidates of oncoplastic 
reconstruction.26,44,45 Oncological safety is one of the 
most prominent advantages of partial breast 
reconstruction.40 Anderson et al. investigated different 
oncoplastic approaches for partial mastectomy. Partial 
breast reconstruction is capable of enhancing the 
probability of achieving better surgical margins. Surgical 
treatments of breast cancer have their own advantages 
and disadvantages. Oncoplastic breast surgery can be 
used to obtain optimal aesthetic outcomes for women 
with breast cancers, especially for women who would not 
obtain acceptable outcomes with other techniques. It is 
essential to apply oncoplastic principles to mastectomy 
and reconstruction and to understand the different 
varieties of mastectomy techniques to obtain the better 
outcomes, but further research is required to examine the 
capacities of some other methods, such as flap 
operations.  
Limitations of Oncoplastic Breast Surgery 
Oncoplastic breast surgery may delay the adjuvant 
therapy and lead to some complications. Complications 
of oncoplastic reconstruction are nipple areola complex 
necrosis, skin/flap necrosis, seroma, hematoma, 
infection, fat necrosis and wound dehiscence. Recently, 
it was reported that the average complication rate for the 
oncoplastic reduction mammaplasty group and the 
oncoplastic flap reconstruction group was 16% and 14%, 
respectively. Accordingly, the initiation of adjuvant 
therapy was not delayed. Complications in oncoplastic 
groups may not negatively affect patient care. To reduce 
morbidity rate, it is essential to select proper techniques.  
Conclusion 
Oncoplastic approaches are used to obtain better 
outcomes for women with breast cancer, attempting to 
minimize cosmetic detriment to the breast.  
List of acronyms 
BCS - breast conserving surgery 
BCT – breast-conservaing therapy 
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